Identification and partial purification of a human natural killer cell proliferation-inducing factor

Journal of Biosciences

Volumn 21, Issue 4, 1996, Pages 455-469

  Saxena, Queen B ^a   Saxena, Rajiv K ^b   Goldfarb, Ronald H ^a   Herberman, Ronald B ^a   Whiteside, Theresa L ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Cytokines; Interleukins; MHC AF; Mitogen; NK cells; Protein purification

Indexed keywords

EID: 0010338832     PISSN: 02505991     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02703210     Document Type: Article

References (25)

1. Alderson M R, Pike B C, Harada N, Tominaga A, Takatsu K and Nossal G V 1987 Recombinant T cell replacing factor (interleukin 5) acts with antigen to promote the growth and differentiation of single hapten specific B lymphocytes: J. Immunol. 139 2656-2660
2. Boyum A 1974 Separation of blood leukocytes, granulocytes and lymphocytes; Tissue Antigens 4 269-274
3. Caligiuri M A, Zmuidzimas A, Manley T S, Levine H, Smith K A and Ritz J 1990 Functional consequences of interleukin 2 receptor expression on resting human lymphocytes, J. Exp. Med. 171 1509-1526
4. Gillis S, Ferm M M, Ou W and Smith K A 1978 T cell growth factor: Parameters of production and a quantitative microassay for activity: J Immunol. 120 2027-2032
5. Grabstein K H, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn A, Andieh M, Johnson L, Alderson M R. Watson J D, Anderson D M and Giri J G 1994 Cloning of a T cell growth factor that interacts with the interleukin-2 receptor; Science 264 965-968
6. Heo D S, Whiteside T L, Johnson J T, Chen K, Lawrence E L and Herberman R B 1987 Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck; Cancer Res 47 1-6
7. Hercend T, Farace F, Baume D, Charpenter F, Droz J P, Triebel F and Escudier B 1990 Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin 2. A feasibility trial in metastatic renal cell carcinoma; J. Biol. Resp. Modif. 9 546-555
8. Ihle J N and Weinstein Y 1986 Immunological regulation of hematopoietic/lymphoid stem cell differentiation by interleukin 3; Adv. Immunol. 39 1-50
9. Kobayashi M, Fitz L, Ryan M, Hevick R M, Clark S C, Chan S, Loudon R, Sherman F, Perussia B and Trinchieri G 1989 Identification and purification of natural killer cell stimulatory factor (NKSF); J. Exp. Med. 170 827-845
10. - T lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer; Cancer Res. 51 3891-3899
11. Metcalf D 1985 The granulocyte-macrophage colony stimulating factors; Science 229 16-22
12. Namen A E, Schmierer A, March C J, Overell R W, Park L S, Urdal D L and Mochizuki D Y 1988 B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J. Exp. Med. 167 988-1002
13. Paul W E and Ohara J 1987 B cell stimulatory factor-1/interleukin 4; Annu. Rev Immunol. 5 429-459
14. Pricop L, Galatiuc C, Manciulea M, DeLeo A, Sulica A, Whiteside T Land Herberman RB 1991 Expression of Feu receptors on human natural killer cells; Clin. Immunol. Immunopathol. 59 355-367
15. Rabmowich H, Sedlmayr P, Herberman R B and Whiteside T L 1991 Increased proliferation, lytic activity and purity of natural killer cells co-cultured with mitogen-activated feeder cells; Cell. Immunol. 135 454-470
16. Rosenberg S A and Lotze M T 1986 Cancer immunotherapy using interleukin 2 and IL2-activated lymphocytes; Annu. Rev. Immunol. 4 681-709
17. Saxena R K 1987 A spleen cell derived factor imparts resistance to NK cell mediated lysis in a mouse lymphoma cell line: Immunol. Lett. 15 105-108
18. Saxena Q B, Mezey E and Adler W A 1980 Regulation of natural killer activity in vivo. II The effect of alcohol consumption on human peripheral blood natural killer activity; Int. J. Cancer 26 413-417
19. Saxena R K, Saxena Q B, Sarin A and Herberman R B 1992 Natural killer-resistance inducing factor (NK-RIF): A new immuno-modulatory cytokine; in Natural killer cells: Receptors, signalling and mechanisms (eds) E Lotzova and R B Herberman (New York: CRC Press) pp 381-392
20. Saxena R K, Saxena Q B, Whiteside T L, Goldfarb R H and Herberman R B 1996 Partial purification and characterization of a novel human factor that augments the expression of class I MHC antigens on tumour cells; J. Biosci. 21 13-25
21. Stern A S, Podlaski F, Hulmes J D, Pan Y E, Oumer P M, Wolitzky A G, Fanilleti P C, Stremlo D L, Truitt T, Chizzoniti R and Gately H K 1990 Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B lymphoblastoid cells; Proc. Natl. Acad. Sci. USA 87 6808-6812
22. Whiteside T L, Ernstoff M S, Nair S, Kirkwood J M and Herberman R B 1990 In vitro generation and in vivo effects of adherent-lymphokine activated killer (A-LAK) cells and IL2 in patients with solid tumour; in Natural killer cells: Biology and clinical application, (ed) R E Schmidt (6th Int. NK Cell Workshop, Goslar, Hannover Basel, Karger, Switzerland) pp 293-302
23. Whiteside T L, Heo D S, Takagi S, Johnson J T, Iwatsuki S and Herberman R B 1987 Cytolytic anti-tumour cells in long-term cultures of human tumour-infiltrating lymphocytes in recombinant interleukin 2; Cancer Immunol. Immunother. 47 6353-6357
24. Wibke E A, Lotze M T and Rosenberg S A 1987 Tumour cell susceptibility to lysis: marked increase in lysis by tumour-infiltrating lymphocytes following target stimulation with interferon-gamma and tumour necrosis factor-alpha; Implicat. Immunother. Surg. Forum. 38 436-441
25. Wysocki L J and Sato V L 1978 "Panning" for lymphocytes: A method for cell selection; Proc. Natl. Acad. Sci. USA 75 2844-2849